Fri Oct 18 14:40:00 UTC 2024: ## Bright Minds Biosciences Shares Soar After Announcing $35 Million Private Placement
**SAN FRANCISCO, CA -** Bright Minds Biosciences (NASDAQ:DRUG) saw its shares surge by nearly 48% in pre-market trading on Friday, recovering from two days of decline. The boost came after the psychedelic drug developer announced a private placement agreement to raise up to $35 million in gross proceeds.
The company plans to use the funds to advance its clinical development programs, which focus on innovative treatments for neurological and psychiatric disorders using psychedelic-derived therapies.
The successful private placement demonstrates investor confidence in Bright Minds Biosciences’ potential to revolutionize mental health treatment. The company’s focus on psychedelic-assisted therapies aligns with a growing global trend towards exploring alternative approaches to mental health conditions.
This news comes at a time when the psychedelic drug industry is experiencing a surge of interest and investment, with numerous companies emerging to explore the therapeutic potential of these substances.
Bright Minds Biosciences is poised to capitalize on this momentum, and its recent capital raise positions the company for continued growth and development. The market is watching closely to see how the company utilizes these funds to push its research and clinical trials forward.
First Piper 